Safe Fertility Group Valuation
Is SAFE-F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SAFE-F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SAFE-F (THB21) is trading above our estimate of fair value (THB17.81)
Significantly Below Fair Value: SAFE-F is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SAFE-F?
Other financial metrics that can be useful for relative valuation.
What is SAFE-F's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿6.23b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5.7x |
Enterprise Value/EBITDA | 17x |
PEG Ratio | 1.5x |
Price to Earnings Ratio vs Peers
How does SAFE-F's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 33.1x | ||
KLINIQ Klinique Medical Clinic | 28.2x | 22.6% | ฿8.1b |
GFC Genesis Fertility Center | 31.2x | 19.9% | ฿2.4b |
BKGI Bangkok Genomics Innovation | 57.1x | n/a | ฿1.8b |
D Dental Corporation | 15.9x | n/a | ฿1.1b |
SAFE-F Safe Fertility Group | 30.9x | 20.8% | ฿6.2b |
Price-To-Earnings vs Peers: SAFE-F is good value based on its Price-To-Earnings Ratio (30.9x) compared to the peer average (33.3x).
Price to Earnings Ratio vs Industry
How does SAFE-F's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: SAFE-F is expensive based on its Price-To-Earnings Ratio (30.9x) compared to the TH Healthcare industry average (25.8x).
Price to Earnings Ratio vs Fair Ratio
What is SAFE-F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 30.9x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SAFE-F's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.